Strides receives USFDA approval for Naproxen Sodium OTC Softgel capsules
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Naproxen Sodium Capsules, 220 mg, of Bionpharma
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Naproxen Sodium Capsules, 220 mg, of Bionpharma
Strides is the first Indian company to get approval for the product.
Mittal will be driving expansion of the provider network across India
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Perrigo expects to launch Omeprazole Minis later this year
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
Subscribe To Our Newsletter & Stay Updated